Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL MICROBIOLOGY
Volume 66, Issue 7, Pages 946-958
Publisher
Microbiology Society
Online
2017-07-19
DOI
10.1099/jmm.0.000527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response
- (2016) Afshin Zariri et al. INFECTION AND IMMUNITY
- Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
- (2016) Luana Maggiore et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain
- (2016) Soma Mitra et al. VACCINE
- Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis
- (2016) William T. Casey et al. VACCINE
- Status of vaccine research and development for Shigella
- (2016) Sachin Mani et al. VACCINE
- The outer membrane phospholipase A is essential for membrane integrity and type III secretion inShigella flexneri
- (2016) Xia Wang et al. Open Biology
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Vaccination with outer membrane vesicles from Francisella noatunensis reduces development of francisellosis in a zebrafish model
- (2015) Espen Brudal et al. FISH & SHELLFISH IMMUNOLOGY
- A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles
- (2015) Sandro Roier et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria
- (2015) Jana Klimentová et al. MICROBIOLOGICAL RESEARCH
- World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis
- (2015) Martyn D. Kirk et al. PLOS MEDICINE
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Protection against Lethal Sepsis
- (2014) Wildaliz Nieves et al. Clinical and Vaccine Immunology
- Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine
- (2014) R. W. Kaminski et al. Clinical and Vaccine Immunology
- A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato
- (2014) Nina Wressnigg et al. Clinical and Vaccine Immunology
- Identification and Characterization of Outer Membrane Vesicle-Associated Proteins in Salmonella enterica Serovar Typhimurium
- (2014) Jaewoo Bai et al. INFECTION AND IMMUNITY
- Modulation of Endotoxicity ofShigellaGeneralized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications
- (2014) Omar Rossi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes
- (2014) María Emilia Gaillard et al. VACCINE
- Estimating Diarrheal Illness and Deaths Attributable to Shigellae and Enterotoxigenic Escherichia coli among Older Children, Adolescents, and Adults in South Asia and Africa
- (2014) Laura M. Lamberti et al. PLoS Neglected Tropical Diseases
- Bacterial Outer Membrane Vesicles and Vaccine Applications
- (2014) Reinaldo Acevedo et al. Frontiers in Immunology
- Protein selection and export via outer membrane vesicles
- (2013) K.E. Bonnington et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Analysis of the Proteome of Intracellular Shigella flexneri Reveals Pathways Important for Intracellular Growth
- (2013) Rembert Pieper et al. INFECTION AND IMMUNITY
- Multiplexed immunoassay to assess Shigella-specific antibody responses
- (2013) Robert W. Kaminski et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Immunization with Escherichia coli Outer Membrane Vesicles Protects Bacteria-Induced Lethality via Th1 and Th17 Cell Responses
- (2013) O. Y. Kim et al. JOURNAL OF IMMUNOLOGY
- Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis
- (2013) Bas van de Waterbeemd et al. PLoS One
- Outer membrane protein A (OmpA) from Shigella flexneri 2a: A promising subunit vaccine candidate
- (2013) Debasis Pore et al. VACCINE
- Towards a non-living vaccine against Shigella flexneri: From the inactivation procedure to protection studies
- (2012) A.I. Camacho et al. METHODS
- High Yield Production Process for Shigella Outer Membrane Particles
- (2012) Francesco Berlanda Scorza et al. PLoS One
- Eight Stranded β -Barrel and Related Outer Membrane Proteins: Role in Bacterial Pathogenesis
- (2012) Siobhan McClean PROTEIN AND PEPTIDE LETTERS
- The bacterial outer membrane β-barrel assembly machinery
- (2012) Kelly H. Kim et al. PROTEIN SCIENCE
- A Bilayer-Couple Model of Bacterial Outer Membrane Vesicle Biogenesis
- (2012) J. W. Schertzer et al. mBio
- Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
- (2011) Xilian Bai et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
- (2011) Francisco J. Martinez-Becerra et al. INFECTION AND IMMUNITY
- Outer Membrane Protein A (OmpA) of Shigella flexneri 2a, Induces Protective Immune Response in a Mouse Model
- (2011) Debasis Pore et al. PLoS One
- Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice
- (2011) A.I. Camacho et al. VACCINE
- Th17 Cells Are the Dominant T Cell Subtype Primed by Shigella flexneri Mediating Protective Immunity
- (2010) Gernot Sellge et al. JOURNAL OF IMMUNOLOGY
- Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process
- (2010) Bas van de Waterbeemd et al. VACCINE
- Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
- (2010) Justen H. Passwell et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation